:neuroscience, molecular medicine, and the therapeutic transformation of neurology
First Statement of Responsibility
/ edited by Stephen Waxman
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Amsterdam ;Boston
Name of Publisher, Distributor, etc.
: Elsevier Academic Press,
Date of Publication, Distribution, etc.
, c2005.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
x, 513 p., [24] p. of plates
Other Physical Details
: ill. (some col.) ; 29 cm.
NOTES PERTAINING TO PUBLICATION, DISTRIBUTION, ETC.
Text of Note
e
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index.
CONTENTS NOTE
Text of Note
Cellular plasticity of the adult human brain -- Harnessing endogenous stem cells for central nervous system repair -- Neuropathies-translating causes into treatments -- Inherited neuropathies -- Therapeutic potential of neurotrophic factors -- Promoting the regeneration of axons within the central nervous system -- Alzheimer's disease: clinical features, neuropathological and biochemical abnormalities, genetics, models, and experimental therapeutics -- Behavioral intervention and recovery from CNS damage -- What functional brain imaging will mean for neurology.
Text of Note
Seeing the brain so we can save it: the evolution of magnetic resonance -- Imaging as a clinical tool -- Advances in the acute treatment and secondary prevention of stroke -- Preserving function in acute nervous system injury -- Slowing the progression of multiple sclerosis -- The emergence of neurosurgical approaches to the treatment of epilepsy -- The neurobiology of migraine and transformation of headache therapy -- Botulinum toxins: transformation of a toxin into a treatment -- Prospects for slowing the progression of Parkinson's disease -- Current neurosurgical treatments for Parkinson's disease: where did they come from? -- Treatable peripheral neuropathies: plasma exchange, intravenous immunoglobulin, and other emerging therapies -- Molecular pharmacology and the treatment of Tourette's syndrome and attention deficit-hyperactivity disorder -- Neuroscience, molecular medicine, and new approaches to the treatment of depression and anxiety -- Genomics, proteomics, and neurology -- Neuroprotection: where are we going? -- Prospects for gene therapy for central nervous system disease -- Therapeutics development for hereditary neurological diseases -- Inherited channelopathies of the CNS: lessons for clinical neurology -- Inherited channelopathies of muscle: implications for therapy -- Transcriptional channelopathies of the nervous system: new targets for molecular medicine -- New molecular targets for the treatment of neuropathic pain -- Therapeutic transfer and regeneration of neural progenitors or neurons in gray matter of the adult brain --